Heidelberg Pharma AG buy melinda
Start price
15.11.17
/
50%
€2.98
Target price
16.01.18
€4.00
Performance (%)
20.81%
End price
16.01.18
€3.60
Summary
This prediction ended on 16.01.18 with a price of €3.60. The BUY prediction by melinda finished with a performance of 20.81%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Heidelberg Pharma AG | 0.000% | 0.000% | -24.041% | -51.471% |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
According to melinda what are the pros and cons of Heidelberg Pharma AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Heidelberg Pharma AG diskutieren
Biotechnologie und medizinische SecteurRecherche
Heidelberg Pharma AG ist für den Nachweis für die Entwicklung von diagnostischen und therapeutischen Produkten verpflichtet und gezielte Behandlung von verschiedenen Arten von cancer.Il folgenden Segmenten arbeitet durch: Suche bestimmte Kunden (Cx), Diagnostics (Dx) und therapeutische ( Rx) .Die Kundenspezifische
Stopped prediction by melinda for Heidelberg Pharma AG
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.68
16.03.20
16.03.20
€3.00
04.11.21
04.11.21
120.15%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.08
15.10.18
15.10.18
€2.45
18.10.18
18.10.18
8.17%
18.10.18
18.10.18
Could be worthwhile Investment >10% per year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.98
15.11.17
15.11.17
€4.00
16.01.18
16.01.18
20.81%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year